Status
Conditions
About
The ASSERT-III study aims to determine the incidence of sub-clinical (silent) atrial fibrillation (AF) among elderly patients with hypertension and at least one other risk factor for AF. This will be accomplished by monitoring with a wireless external loop monitor for 30 to 60 days.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients will be eligible for inclusion if they meet all of the following:
Age ≥ 80 years
History of hypertension OR a blood pressure of ≥ 140/90 mmHg
Attending a primary care clinic, OR ambulatory resident of a chronic care facility
At least one of the following additional risk factors for developing AF:
Provide written informed consent
Exclusion criteria
ECG documented history of AF or atrial flutter, with an episode duration ≥ 6 minutes
Existing implanted pacemaker or defibrillator
Patients considered by the investigator to be unsuitable for study follow-up because the patient:
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal